Single-use biophotonic device for cervical cancer screening targets developing world

Guided Therapeutics (Norcross, GA) is now shipping its single-use disposable Cervical Guide that works with the company's LuViva Advanced Cervical Scan platform, a biophotonic system that scans the cervix with light and uses spectroscopy to measure how light interacts with the cervical tissue.

Related: Guided Therapeutics begins FDA premarket approval process for cervical cancer detector

Screening women for cervical cancer offers one of the largest opportunities available in diagnostic medicine, as cervical cancer is linked to human papillomavirus (HPV; a sexually transmitted disease). In the developing world, there are approximately 2 billion women aged 15 and older who are potentially eligible for screening with LuViva. Screening for cervical cancer in the developing world also presents the opportunity to work with governments, who can provide immediate access to large numbers of lives covered under national or regional governmental healthcare programs.

Gene Cartwright, CEO and president of Guided Therapeutics, says that the company will be introducing the new Cervical Guides in the coming months in 2016 in Turkey, Bangladesh, Indonesia, Kenya, and Nigeria, where it is actively working with distributors to implement government-sponsored screening programs. The number of screening candidates in those countries is approximately 246 million and represents three of the 10 most populous countries in the world, he adds.

Internationally, the company has regulatory approval to sell LuViva in Europe, which became effective in January 2014. LuViva has marketing approval from Health Canada, COFEPRIS (Mexico), the Ministry of Health (Kenya), and the Singapore Health Sciences Authority.

For more information, please visit

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

'Lab on a stick' test optically and rapidly detects antibiotic resistance

A point-of-care test, based on the dipstick method, can rapidly detect bacterial resistance to antibiotics in urine.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS